Natuheal Wart Remover

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by a rough, cauliflower-like appearance.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to follow the outlined procedure for the application of the medication to ensure optimal results.

The affected area should be washed thoroughly, and soaking in warm water for approximately 5 minutes may facilitate this process. After cleansing, the area must be dried completely to ensure proper adhesion of the medication.

A small amount of the medication should be applied directly to cover each wart. It is important to allow the application to dry completely before proceeding with any additional activities.

This application should be repeated twice daily as needed, with a maximum treatment duration of up to 12 weeks. Regular monitoring of the treatment area is recommended to assess the effectiveness and any potential side effects.

Contraindications

Use of this product is contraindicated in the following situations:

Application on irritated or infected skin, or on areas exhibiting redness, is not recommended due to the potential for exacerbating the condition.

Patients with diabetes or poor blood circulation should avoid use, as these conditions may increase the risk of adverse effects.

Additionally, the product should not be applied to birthmarks, warts with hair growth, or moles, as these may present a risk of irritation or other complications.

Warnings and Precautions

The product is intended for external use only and should be applied with caution to avoid contact with the eyes. In the event of accidental eye exposure, it is imperative to rinse the eyes thoroughly with water for at least 15 minutes. Additionally, users should avoid inhaling vapors associated with the product.

General precautions should be observed when using this product. It is not recommended for application on irritated or infected skin, or on areas that are reddened. Caution is advised for individuals with diabetes or poor blood circulation, as well as for use on birthmarks, warts with hair growth, or moles.

In case of ingestion, immediate medical assistance should be sought, or the user should contact a Poison Control Center without delay.

Users are advised to discontinue use and consult a healthcare professional if discomfort persists following application.

Side Effects

Patients should be aware that the product is intended for external use only and must be kept away from the eyes. In the event of contact with the eyes, it is recommended to rinse thoroughly with water for 15 minutes. Additionally, patients should avoid inhaling vapors associated with the product.

In clinical practice, if discomfort persists after using the product, patients are advised to discontinue use and consult a healthcare professional for further guidance. This precaution is essential to ensure the safety and well-being of individuals using the product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Natuheal Wart Remover (salicylic acid 17% wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is essential to evaluate the potential risks and benefits in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions provided for individuals with compromised liver function. It is recommended that healthcare professionals exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not outlined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, altered mental status, cardiovascular instability, or gastrointestinal disturbances.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. Healthcare professionals should also consider contacting a poison control center for additional guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, monitor for symptoms, and provide appropriate supportive care in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical help or contact a Poison Control Center if the product is swallowed. It is important to inform patients that the product should not be applied to irritated or infected skin, or to areas that are reddened.

Patients with diabetes or poor blood circulation should be cautioned against using the product on birthmarks, warts with hair growth, or moles. Healthcare providers should encourage patients to stop use and consult a doctor if discomfort persists after application.

Additionally, it is essential for healthcare providers to recommend that patients who are pregnant or breastfeeding consult a health professional before using the product to ensure safety for both the patient and the child.

Storage and Handling

The product is supplied in a tube format, with specific handling and storage requirements to ensure its integrity and efficacy. It should be stored at room temperature, away from direct light exposure. To maintain the product's quality, the tube must be kept tightly closed when not in use. Additionally, it is recommended to discard the product after opening if it is not utilized within a specified time frame.

Additional Clinical Information

The product is administered topically, with a recommended application of a small amount to cover each wart. Patients should allow the application to dry and may repeat this process twice daily as needed, for a maximum duration of 12 weeks.

Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Natuheal Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)